RecruitingNot ApplicableNCT06511141
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Sacral Neuromodulation for Male Overactive Bladder
Sponsor
Axonics, Inc.
Enrollment
150 participants
Start Date
Oct 22, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
To assess the post-market clinical outcomes of the Axonics SNM System for treatment of overactive bladder in male patients.
Eligibility
Sex: MALEMin Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study is evaluating sacral neuromodulation (a small implanted device that sends mild electrical signals to the nerves controlling the bladder) as a treatment for overactive bladder (OAB) in men — a condition causing urgent and frequent urges to urinate, or leaking urine before reaching the toilet.
**You may be eligible if...**
- You are a male aged 18 or older
- You have been diagnosed with overactive bladder (with urgency incontinence or urinary frequency as your primary problem)
- You are willing to complete bladder diaries and questionnaires
- You are able to attend all follow-up visits for up to one year
**You may NOT be eligible if...**
- You have had prostate surgery or a prostate procedure in the past 6 months
- Your doctor determines you are not a suitable candidate
- You have other conditions that prevent participation
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEAxonics SNM System
To assess clinical outcomes of the Axonics SNM System in the male OAB population.
Locations(21)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06511141
Related Trials
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
NCT072253092 locations
A Clinical Study of HRS-7525 Tablets in Patients With Advanced Prostate Cancer
NCT07711184
Precision-Based Genomics in Prostate Cancer
NCT0470666311 locations
Collection of Blood From Patients With Cancer
NCT000342161 location
Self-Start Triage Model for Post-Botox® Lower Urinary Tract Symptoms
NCT07648290